Research workbench
The crystal structure of human adenovirus 2 penton base
Analyse The crystal structure of human adenovirus 2 penton base in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 1X9P
- Type
- protein
- Length
- 460 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Penton protein
- UniProt
- P03276
- Ligands
- C15, SO4
- Pockets
- 5 · best druggability 0.71
Structure
x-ray diffraction · 1 distinct chain · 15% helix, 32% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Penton protein | protein | 460 | 15% helix, 32% strand | P03276 |
Ligands and binding sites
- C15 · N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate · ligand · 2 copies · chains A
- SO4 · Sulfate ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 65 | 0.71 | 0.97 | 17 | empty |
| 2 | 215 | 0.57 | 0.79 | 33 | empty |
| 3 | 249 | 0.53 | 0.76 | 29 | empty |
| 4 | 126 | 0.49 | 0.79 | 16 | empty |
| 5 | 85 | 0.34 | 0.74 | 21 | empty |
Compared structures
- 1X9P · The crystal structure of human adenovirus 2 penton base · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P03276
- Elsewhere: RCSB PDB 1X9P · PDBe 1X9P · UniProt P03276
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.